C

Curis

D
CRIS
USD
-0.15
(-2.5084%)
Market Closed
348.00
Volume
-8.09
EPS
-
Div Yield
-0.713586
P/E
34,857,249.35
Market Cap
Today
-2.5084%
1 Week
16.834%
1 Month
33.716%
6 Months
-43.617%
12 Months
-37.846%
Year To Date
-54.418%
All Time
0%
News

Treasury Yields Decline as Market Anticipates Fed Rate Cuts

26.08.2024
Economy news

Novo Nordisk Surges in Profit and Sales

02.05.2024
Stocks news
More
Related Instruments
C
CLSD
-0.02
(-1.5267%)
USD
C
CAPR
-0.165
(-3.1977%)
USD
C
CARA
0.0089
(2.9966%)
USD
C
CRNX
1.13
(2.1414%)
USD
C
CRVS
0.07
(1.275%)
USD
C
CRDF
0.055
(2.2267%)
USD
C
CRSP
-0.11
(-0.2219%)
USD

Title:
Curis

Sector:
Healthcare
Industry:
Biotechnology
Curis Inc is a biotechnology company that develops and commercializes innovative drugs and therapies in the immuno-oncology and precision oncology therapeutic areas. The company targets solid tumors, diffuse large B-cell lymphoma, advancedsolid tumors or lymphomas, hematological cancers, and others. Its pipeline products include Fimepinostat, CA-170, CA-4948, CA-327, and Erivedge.
Do you need help or have a question?
Contact Us